Sunitinib malate is active against human urothelial carcinoma and enhances the activity of cisplatin in a preclinical model

Published 2008 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
Sunitinib malate is active against human urothelial carcinoma and enhances the activity of cisplatin in a preclinical model
Authors
Keywords
-
Journal
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
Volume 27, Issue 4, Pages 391-399
Publisher
Elsevier BV
Online
2008-06-05
DOI
10.1016/j.urolonc.2008.03.017

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.